J M Baena-Díez1, M Grau2, R Forés3, D Fernández-Bergés4, R Elosua5, M Sorribes6, F J Félix-Redondo7, A Segura8, F Rigo9, A Cabrera de León10, H Sanz2, J Marrugat2, J Sala11. 1. Centro de Salud La Marina e Institut d'Investigació en Atenció Primària Jordi Gol, Institut Català de la Salut, Barcelona, España; Grupo de Epidemiología y Genética Cardiovascular; Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM, Barcelona, España. 2. Grupo de Epidemiología y Genética Cardiovascular; Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM, Barcelona, España. 3. Centro de Salud Riu Nord-Riu Sud, USR Metropolitana Nord, Institut d'Investigació en Atenció Primària Jordi Gol, Institut Català de la Salut, Barcelona, España. 4. Unidad de Investigación Grimex, Programa de Investigación Cardiovascular (Pericles), Don Benito-Villanueva, Badajoz, España; Sección de Cardiología, Servicio Medicina Interna Hospital Don Benito-Villanueva, Badajoz. España. Electronic address: polonibo@gmail.com. 5. Grupo de Epidemiología y Genética Cardiovascular; Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM, Barcelona, España; CIBER Epidemiología y Salud Pública (CIBERESP), España. 6. Centro de Salud Numancia, Institut Català de la Salut, Barcelona, España. 7. Unidad de Investigación Grimex, Programa de Investigación Cardiovascular (Pericles), Don Benito-Villanueva, Badajoz, España; Centro de Salud Villanueva Norte, Servicio Extremeño de Salud, Villanueva de la Serena, Badajoz, España. 8. Servicio de Investigación, Instituto de Ciencias de la Salud de Castilla-La Mancha, Talavera de la Reina, Toledo, España. 9. Grupo Cardiovascular de Baleares de redIAPP, UB Genova, Palma de Mallorca, España. 10. Unidad de Investigación de Atención Primaria y del Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España; Área de Medicina Preventiva y Salud Pública, Universidad de La Laguna, La Laguna, España. 11. Grupo de Epidemiología y Genética Cardiovascular; Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM, Barcelona, España; Servicio de Cardiología, Hospital Josep Trueta, Institut Català de la Salut, Barcelona, España.
Abstract
BACKGROUND AND OBJECTIVES: Atrial fibrillation (AF) is the most common type of arrhythmia. The purpose of this study was to determine the prevalence of atrial fibrillation and its relationship with cardiovascular risk factors in Spain. METHODOLOGY: Cross-sectional study based on a grouped analysis of 17,291 randomized individuals recruited in 6 population studies. RESULTS: The prevalence of atrial fibrillation was 1.5% (95% CI:1.3-1.7%). Men had a greater prevalence of the disease than women (1.9 vs. 1.1%, respectively). The prevalence of atrial fibrillation progressively increased with age: 0.05% for patients younger than 45 years, 0.5% for those between 45-59 years of age, 2.3% for those between 60-74 years of age and 6.3% for those older than 75 years. The percentage of individuals who were underwent anticoagulant treatment was 74.3%. The risk factors significantly associated with arrhythmia were an age older than 60 years (odds ratio [OR]: 7.6; 95% CI: 5.1-11.2), the male sex (OR:1.8; 95% CI: 1.4-2.4), arterial hypertension (OR:1.6; 95% CI: 1.2-2.1), obesity (OR:1.5; 95% CI:1.2-2.1) and a history of coronary artery disease (OR:1.9; 95% CI: 1.3-3.0). CONCLUSION: Atrial fibrillation is a common disease in elderly individuals, while its prevalence is low in individuals younger than 60 years. Most individuals with atrial fibrillation were on anticoagulant treatment. The risk factors for this type of arrhythmia are age, the male sex, hypertension, obesity and a history of coronary artery disease.
BACKGROUND AND OBJECTIVES:Atrial fibrillation (AF) is the most common type of arrhythmia. The purpose of this study was to determine the prevalence of atrial fibrillation and its relationship with cardiovascular risk factors in Spain. METHODOLOGY: Cross-sectional study based on a grouped analysis of 17,291 randomized individuals recruited in 6 population studies. RESULTS: The prevalence of atrial fibrillation was 1.5% (95% CI:1.3-1.7%). Men had a greater prevalence of the disease than women (1.9 vs. 1.1%, respectively). The prevalence of atrial fibrillation progressively increased with age: 0.05% for patients younger than 45 years, 0.5% for those between 45-59 years of age, 2.3% for those between 60-74 years of age and 6.3% for those older than 75 years. The percentage of individuals who were underwent anticoagulant treatment was 74.3%. The risk factors significantly associated with arrhythmia were an age older than 60 years (odds ratio [OR]: 7.6; 95% CI: 5.1-11.2), the male sex (OR:1.8; 95% CI: 1.4-2.4), arterial hypertension (OR:1.6; 95% CI: 1.2-2.1), obesity (OR:1.5; 95% CI:1.2-2.1) and a history of coronary artery disease (OR:1.9; 95% CI: 1.3-3.0). CONCLUSION:Atrial fibrillation is a common disease in elderly individuals, while its prevalence is low in individuals younger than 60 years. Most individuals with atrial fibrillation were on anticoagulant treatment. The risk factors for this type of arrhythmia are age, the male sex, hypertension, obesity and a history of coronary artery disease.
Authors: Javier Azaña Gómez; Luis M Pérez-Belmonte; Manuel Rubio-Rivas; José Bascuñana; Raúl Quirós-López; María Luisa Taboada Martínez; Esther Montero Hernandez; Fernando Roque-Rojas; Manuel Méndez-Bailón; Ricardo Gómez-Huelgas Journal: Med Clin (Barc) Date: 2022-03-10 Impact factor: 1.725
Authors: Francisco Javier Félix-Redondo; Luis Lozano Mera; Luciano Consuegra-Sánchez; Fernando Giménez Sáez; Francisco Javier Garcipérez de Vargas; José María Castellano Vázquez; Daniel Fernández-Bergés Journal: Open Heart Date: 2016-02-26